PATENT CLAIM ANALYSIS

Application Number: 16228835
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["514", "253120"]

Abstract:
Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the neurokinin (NK 1 ) receptor. The compounds have the general formula (I):

Claim (Index 6):
The compound of  claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound of formula (I) has a structure of formula (III): where R 8  is selected from the group consisting of hydrogen, alkyl, alkenyl and cycloalkyl, each optionally independently substituted with one or more independent R 103  substituents; R 9  is alkyl or cycloalkyl, each optionally substituted with one or more independent R 103  substituents; and all other radicals are defined according to formula (I) and formula (II).

Metadata:
- Claim Count in Document: 17.0
- Percentile: 98.0
- Lexical Diversity: 1.19355
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15194984', '15874325', '14360991', '12637719', '11582293']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8266563745159912
- 35 USC 102 Novelty (BERT): 0.5404934177808097
- Combined Prediction Score: 0.7980400788424731
- Mean Citation Score: 329.305366
- Max Citation Score: 397.34216
- Similarity Product: 299.7476132329512

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test